Recent research from the UCLA Health Jonsson Comprehensive Cancer Center suggests that Manuka honey may offer therapeutic benefits in treating breast cancer, particularly estrogen receptor (ER)-positive breast cancer. The study, published in the journal Nutrients, highlights the potential of this unique honey as part of a treatment regimen.
Manuka Honey and Breast Cancer
Manuka honey, derived from the nectar of the Manuka tree native to New Zealand and parts of Australia, contains compounds like flavonoids and phytoestrogens. These components may contribute to its therapeutic properties. Richard Pietras, a professor of medicine specializing in Hematology-Oncology, noted that Manuka honey's unique nutrients and bioactive compounds likely contribute to its health benefits as a nutraceutical.
Preclinical Study Details
The UCLA team's research involved administering human breast cancer cell lines (MCF-7 cells) to female nude mice. After tumors developed, the mice were treated with Manuka honey both orally and through injections over 42 days. The results showed a considerable reduction in tumor size, with tumors experiencing up to an 84% reduction. Importantly, the treatment did not cause adverse effects on surrounding healthy cells, suggesting a favorable safety profile compared to traditional chemotherapy.
Implications and Future Research
While these findings are promising, researchers emphasize the preliminary nature of the results. Further studies, especially those involving human subjects, are needed to confirm these effects, determine optimal dosing strategies, and assess potential interactions with other therapies. This research adds to the growing interest in dietary interventions and complementary therapies for cancer patients, potentially bridging the gap between traditional treatments and integrative oncology approaches.
